阿莫西林克拉维酸钾的抗菌活性。 - Suppr | 超能文献

The antibacterial activity of co-amoxiclav.

作者信息

Barry A L, Pfaller M A, Fuchs P C

出版信息

J Antimicrob Chemother. 1993 Apr;31(4):612-5. doi: 10.1093/jac/31.4.612.

DOI:10.1093/jac/31.4.612

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The antibacterial activity of co-amoxiclav.阿莫西林克拉维酸钾的抗菌活性。

J Antimicrob Chemother. 1993 Apr;31(4):612-5. doi: 10.1093/jac/31.4.612.

2

Problems associated with susceptibility testing of co-amoxiclav.与阿莫西林克拉维酸药敏试验相关的问题。

J Antimicrob Chemother. 1993 Mar;31(3):443-5. doi: 10.1093/jac/31.3.443.

3

Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.

Acta Clin Belg. 1988;43(2):109-14. doi: 10.1080/17843286.1988.11717917.

4

[The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].[与其他抗菌药物相比，阿莫西林/克拉维酸（奥格门汀）的抗菌活性]

Antibiot Khimioter. 1992 Sep;37(9):34-6.

5

Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.德国医院临床分离株对阿莫西林/克拉维酸（安灭菌）与其他抗生素的敏感性比较。

Chemotherapy. 1988;34(4):332-40. doi: 10.1159/000238588.

6

[Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].[与迄今使用的其他抗生素相比，对所选细菌对阿莫西林和奥格门汀敏感性的初步评估]

Przegl Lek. 1984;41(4):321-4.

7

Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.嗜麦芽窄食单胞菌对头孢他啶和阿莫西林克拉维酸耐药性的产生

J Antimicrob Chemother. 1991 Aug;28(2):321-4. doi: 10.1093/jac/28.2.321.

8

Problems associated with susceptibility testing of co-amoxiclav: an interpretive solution.与阿莫西林克拉维酸药敏试验相关的问题：一种解释性解决方案。

J Antimicrob Chemother. 1994 Jan;33(1):183. doi: 10.1093/jac/33.1.183.

9

Divergent disk susceptibility of coagulase-negative staphylococci to penicillinase-resistant penicillins and augmentin (amoxycillin/clavulanic acid).凝固酶阴性葡萄球菌对耐青霉素酶青霉素和奥格门汀（阿莫西林/克拉维酸）的药敏盘差异

Chemotherapy. 1985;31(2):119-23. doi: 10.1159/000238323.

10

In vitro efficacy of augmentin in beta-lactamase producing bacteria.

Indian J Med Res. 1987 Sep;86:298-300.

引用本文的文献

1

Analysis of ESAC-Net/EARS-Net Data from 29 EEA Countries for Spatiotemporal Associations Between Antimicrobial Use and Resistance-Implications for Antimicrobial Stewardship?对来自29个欧洲经济区国家的ESAC-Net/EARS-Net数据进行分析，以研究抗菌药物使用与耐药性之间的时空关联——对抗菌药物管理有何启示？

Antibiotics (Basel). 2025 Apr 13;14(4):399. doi: 10.3390/antibiotics14040399.

2

Beta-lactam/beta-lactamase inhibitor combinations: development, antibacterial activity and clinical applications.β-内酰胺类/β-内酰胺酶抑制剂联合制剂：研发、抗菌活性及临床应用

Infection. 1995 Jul-Aug;23(4):191-200. doi: 10.1007/BF01781195.

3

Susceptibility of bacterial respiratory pathogens to amoxicillin and amoxicillin-clavulanic acid.

Eur J Clin Microbiol Infect Dis. 1994 May;13(5):442-4. doi: 10.1007/BF01972009.